NEW YORK (GenomeWeb News) – Biomarker developer TcLand Expression will use Genedata's Phylosopher and Expressionist software platforms in its research programs, Genedata said today.
Under the agreement, TcLand Expressions will integrate the two platforms into its computational infrastructure to support interdisciplinary biomarker identification, validation, and mode-of-action studies that are focused on transplantation and autoimmune disease research. Genedata said that the platforms will enable Nantes, France-based TcLand to "take a cross-technology approach by using automated workflows and integrated analysis tools to streamline the research workflow, from experimental design through to final results."
The Genedata Phylosopher software is used for target discovery and integrative data management, and Expressionist is designed to support biomarker discovery and personalized medicine research.
Financial terms of the agreement were not released.